title: [Skin infection due to Serratia marcescens in an immunocompetent patient].
authors.forename: P
authors.initials: P
authors.lastname: Giráldez
authors.forename: E
authors.initials: E
authors.lastname: Mayo
authors.forename: P
authors.initials: P
authors.lastname: Pavón
authors.forename: A
authors.initials: A
authors.lastname: Losada
mesh_terms: D000038:Abscess / Q000209:etiology; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002481:Cellulitis / Q000209:etiology; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005122:Exudates and Transudates / Q000382:microbiology; D006229:Hand Dermatoses / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D006230:Hand Injuries / Q000150:complications / Q000382:microbiology; D006801:Humans; D007121:Immunocompetence; D008297:Male; D012008:Recurrence; D016868:Serratia Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D012706:Serratia marcescens / Q000302:isolation & purification*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage / Q000627:therapeutic use; D014946:Wound Infection / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D014950:Wounds, Penetrating / Q000150:complications / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination